How rosuvastatin and atorvastatin help lower LDL cholesterol. They also protect the heart and encourage lifestyle changes.

Rosuvastatin (Crestor) is used to treat several types of high cholesterol and to prevent heart disease. Learn about side effects, warnings, dosage, and more.

A head-to-head comparison of two popular lipid-lowering medications suggests that rosuvastatin may be a better option than atorvastatin when it comes to decreasing the risk of all-cause mortality and ...

Six widely used dietary supplements often advertised to promote heart health are actually ineffective at lowering cholesterol levels.

Pune, Maharashtra, India, October 18 2022 (Wiredrelease) Prudour Pvt. Ltd –:The global rosuvastatin calcium market is expected to grow at a CAGR of 5.9% during the forecast period.Rosuvastatin calcium ...

Rosuvastatin for cholesterol lowering was associated with slightly greater risks for kidney harm than atorvastatin, risks that were greater at higher-dose levels, in a large retrospective cohort ...

Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney failure with replacement therapy, according to a study.Further, investigators found ...

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests A 76-year-old woman had a spike in rosuvastatin plasma concentrations after starting the SGLT2 inhibitor.

Treatment with the anticholesterol medicine rosuvastatin calcium did not reduce the risk of fracture among men and women who had elevated levels of an inflammatory biomarker, according to a report ...

Rosuvastatin was also associated with significant reductions in rates of the individual components of the primary trial end point.

Rosuvastatin did not reduce the primary outcome or the number of deaths from any cause in older patients with systolic heart failure, although the drug did reduce the number of cardiovascular ...

Rosuvastatin calcium (Crestor; AstraZeneca), the seventh drug in the statin class, was approved by the US FDA in August 2003 for the reduction of cholesterol levels in patients with ...